TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages 127-142

  Daniels, Garrett ^a   Li, Yirong ^a   Gellert, Lan Lin ^a   Zhou, Albert ^a   Melamed, Jonathan ^a   Wu, Xinyu ^a   Zhang, Xinming ^a   Zhang, David ^b   Meruelo, Daniel ^a   Logan, Susan K ^a   Basch, Ross ^a   Lee, Peng ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen; Androgen receptor; Gene expression; Gene transcription; Prostate

Indexed keywords

ANDROGEN RECEPTOR; TRANSDUCIN; TRANSDUCIN BETA LIKE RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS ASSAY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SITE DIRECTED MUTAGENESIS; TISSUE MICROARRAY;

ANDROGEN; ANDROGEN RECEPTOR; GENE EXPRESSION; GENE TRANSCRIPTION; PROSTATE;

ADENOCARCINOMA; ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; HUMANS; MALE; MICE, NUDE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TISSUE ARRAY ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 84893586067     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0293     Document Type: Article

References (33)

1. Agoulnik IU & Weigel NL 2009 Coactivator selective regulation of androgen receptor activity. Steroids 74 669-674. (doi:10.1016/j.steroids.2009. 02.007)
2. Altuwaijri S, Wu CC, Niu YJ, Mizokami A, Chang HC & Chang C 2007 Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells. Asian Journal of Andrology 9 181-188. (doi:10.1111/j.1745-7262.2007.00258.x)
3. Burke LJ & Baniahmad A 2000 Co-repressors 2000. FASEB Journal 14 1876-1888. (doi:10.1096/fj.99-0943rev)
4. Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, Liebes L, Gerald WL, Pincus MR, Osman I & Lee P 2008 Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Oncogene 27 3201-3210. (doi:10.1038/sj.onc.1210983)
5. Choi HK, Choi KC, Yoo JY, Song M, Ko SJ, Kim CH, Ahn JH, Chun KH, Yook JI & Yoon HG 2011 Reversible SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt signaling. Molecular Cell 43 203-216. (doi:10.1016/j.molcel.2011.05.027)
6. Dehm SM & Tindall DJ 2006 Molecular regulation of androgen action in prostate cancer. Journal of Cellular Biochemistry 99 333-344. (doi:10.1002/jcb.20794)
7. Gao M, Ossowski L & Ferrari AC 1999 Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative. Journal of Cellular Physiology 179 336-346. (doi:10.1002/(SICI)1097-4652(199906) 179:3<336::AID-JCP11>3.0.CO;2-Q)
8. Garcia-Arenas R, Lin FF, Lin D, Jin LP, Shih CC, Chang C & Lin MF 1995 The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells. Molecular and Cellular Endocrinology 111 29-37. (doi:10.1016/0303-7207(95)03544-H)
9. Gelmann EP 2002 Molecular biology of the androgen receptor. Journal of Clinical Oncology 20 3001-3015. (doi:10.1200/JCO.2002.10.018)
10. Gu Y, Kim KH, Ko D, Srivastava S, Moul JW, McLeod DG & Rhim JS 2005 Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line. Anticancer Research 25 1-8.
11. Heinlein CA & Chang C 2002 Androgen receptor (AR) coregulators: an overview. Endocrine Reviews 23 175-200. (doi:10.1210/er.23.2.175)
12. Janne OA, Moilanen AM, Poukka H, Rouleau N, Karvonen U, Kotaja N, Hakli M & Palvimo JJ 2000 Androgen-receptor-interacting nuclear proteins. Biochemical Society Transactions 28 401-405. (doi:10.1042/0300-5127:0280401)
13. Keutgens A, Shostak K, Close P, Zhang X, Hennuy B, Aussems M, Chapelle JP, Viatour P, Gothot A, Fillet M et al. 2010 The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1. Molecular and Cellular Biology 30 4006-4021. (doi:10.1128/MCB.01600-09)
14. Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK & Morton RA 2000 Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Research 60 2840-2844.
15. Kipreos ET & Pagano M 2000 The F-box protein family. Genome Biology 1 REVIEWS3002. (doi:10.1186/gb-2000-1-5-reviews3002)
16. Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X, Pellicer A et al. 2009 LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Research 69 3332-3338. (doi:10.1158/0008-5472.CAN-08-3380)
17. Ligr M, Li Y, Zou X, Daniels G, Melamed J, Peng Y, Wang W, Wang J, Ostrer H, Pagano M et al. 2010 Tumor suppressor function of androgen receptor coactivator ARA70a in prostate cancer. American Journal of Pathology 176 1891-1900. (doi:10.2353/ajpath.2010.090293)
18. Ligr M, Li Y, Logan SK, Taneja S, Melamed J, Lepor H, Garabedian MJ & Lee P 2012 Mifepristone inhibits GRβ coupled prostate cancer cell proliferation. Journal of Urology 188 981-988. (doi:10.1016/j.juro.2012.04.102)
19. Nwachukwu JC, Mita P, Ruoff R, Ha S, Wang Q, Huang SJ, Taneja SS, Brown M, Gerald WL, Garabedian MJ et al. 2009 Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. Cancer Research 69 3140-3147. (doi:10.1158/0008-5472.CAN-08-3738)
20. Peng Y, Chen F, Melamed J, Chiriboga L, Wei J, Kong X, McLeod M, Li Y, Li CX, Feng A et al. 2008a Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgenindependent prostate cancer. PNAS 105 5236-5241. (doi:10.1073/pnas.0712262105)
21. Peng Y, Li CX, Chen F, Wang Z, Ligr M, Melamed J, Wei J, Gerald W, Pagano M, Garabedian MJ et al. 2008b Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70b. American Journal of Pathology 172 225-235. (doi:10.2353/ajpath.2008.070065)
22. Perissi V, Aggarwal A, Glass CK, Rose DW & Rosenfeld MG 2004 A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116 511-526. (doi:10.1016/S0092-8674(04)00133-3)
23. Perissi V, Scafoglio C, Zhang J, Ohgi KA, Rose DW, Glass CK & Rosenfeld MG 2008 TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Molecular Cell 29 755-766. (doi:10.1016/j.molcel.2008.01.020)
24. Thomas MA, Preece DM & Bentel JM 2010 Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 30 untranslated region. Biochemical Journal 425 575-583. (doi:10.1042/BJ20091109)
25. Tomita A, Buchholz DR & Shi YB 2004 Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development. Molecular and Cellular Biology 24 3337-3346. (doi:10.1128/MCB.24.8.3337-3346.2004)
26. Wang P, Ma Q, Luo J, Liu B, Tan F, Zhang Z & Chen Z 2009 Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells. Cancer Investigation 27 369-375. (doi:10.1080/07357900802232749)
27. Wang D, Garcia-Bassets I, Benner C, Li W, Su X, Zhou Y, Qiu J, Liu W, Kaikkonen MU, Ohgi KA et al. 2011 Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474 390-394. (doi:10.1038/nature10006)
28. Whitacre DC, Chauhan S, Davis T, Gordon D, Cress AE & Miesfeld RL 2002 Androgen induction of in vitro prostate cell differentiation. Cell Growth & Differentiation 13 1-11.
29. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J & Wong J 2003 Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO Journal 22 1336-1346. (doi:10.1093/emboj/ cdg120)
30. Yoon HG, Choi Y, Cole PA & Wong J 2005 Reading and function of a histone code involved in targeting corepressor complexes for repression. Molecular and Cellular Biology 25 324-335. (doi:10.1128/MCB.25.1.324-335.2005)
31. Yu SQ, Lai KP, Xia SJ, Chang HC, Chang C & Yeh S 2009 The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian Journal of Andrology 11 39-48. (doi:10.1038/aja.2008.44)
32. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F & Keating A 1993 Androgen-induced inhibition of cell proliferation in an androgeninsensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Research 53 1304-1311.
33. Zhang XM, Chang Q, Zeng L, Gu J, Brown S & Basch RS 2006 TBLR1 regulates the expression of nuclear hormone receptor co-repressors. BMC Cell Biology 7 31. (doi:10.1186/1471-2121-7-31)